Apollomics Announces Private Placement Financing and Addition to Board of Directors
The PIPE financing is expected to close on May 8, 2024, subject to satisfaction of customary closing conditions.
- The PIPE financing is expected to close on May 8, 2024, subject to satisfaction of customary closing conditions.
- Apollomics also announced today the appointment of Dr. Robert (Bob) Lin, M.D., Ph.D. to the board of directors of Apollomics.
- In addition, Jonathan Wang, Ph.D. has resigned from the board of directors, due to personal reasons.
- He brings valuable medical and biotech experience to our Board,” said Dr. Guo-Liang Yu, Ph.D., Chairman and Chief Executive Officer of Apollomics.